Patient Portal Market Comprehensive Assessment, Insights, Facts, and Statistics by 2032

The global patient portal market is expected to be worth USD 3.6 billion by 2022, up from USD 3 billion in 2021. The market is expected to generate USD 22.29 billion by 2032, growing at a double-digit CAGR of 20% between 2022 and 2032. The incorporation of technology in healthcare sectors has contributed to the market's expansion. Patient portals are becoming more popular as IoT and web-based applications become more prevalent.

Patient-centered strategies are gaining traction among healthcare providers and payers. Several businesses have implemented Patient-Centered Healthcare (PCH) programmes as healthcare evolves. Furthermore, patient portal solutions improve care management and ease of use. Healthcare payers and providers are leveraging consumerism to improve their services and provide better healthcare experiences for their users, which is expected to drive market growth even further. Incorporating new digital technologies into a patient-centric strategy, such as EHR and patient portals, provides a variety of benefits, including increased productivity, improved customer experiences, and improved clinical outcomes.

Patient portal providers, on the other hand, must prioritise providing a personalised user experience for patients. Certain patient portals have a complex, difficult-to-understand design. Patients are therefore less likely to use portals as a result. Furthermore, patient portal providers must focus on developing mobile-friendly designs that improve user experience.

Key Takeaways from the Market Study

  • The global patient portal market is expected to be worth US$ 22.29 billion by 2022 to 2032, with a double-digit CAGR of 20%.
  • In the forecast period 2022 to 2032, integrated portals are expected to account for nearly 60% of the patient portal market.
  • In the assessment period 2022 to 2032, web-based software is expected to account for nearly 70% of the patient portal market.
  • Providers are expected to hold around 50% of the patient portal market by end use during the assessment period 2022-2032.
  • During the forecast period, S. is expected to lead the market with a CAGR of 16%.
  • Between 2022 and 2032, Germany is expected to grow at a CAGR of 13%.

“Technological integration along with user-friendly nature of patient portal that provide 24*7 services to patients is increasing the demand for the same.”

Read More Details About Report@ https://www.futuremarketinsights.com/reports/patient-portals-market

Competitive Landscape

Key players in the global patient portal market are Allscripts Healthcare Solutions, Inc, NextGen Healthcare Information Systems, McKesson Corporation, Cerner Corporation, Greenway Health, LLC, athenahealth, Inc, Epic Systems Corporation, GE Healthcare, Medfusion

Key Segments Covered in the Patient Portal Market

By Type:

  • Standalone Patient Portal
  • Integrated Patient Portal

By Delivery Mode:

  • Web-based Patient Portal
  • Cloud-based Patient Portal

By End-Use:

  • Patient Portal for Providers
  • Patient Portal for Payers
  • Others

Comments

Post a Comment

Popular posts from this blog

Portable Oxygen Concentrators Market | Innovative and Technological Advancement

Image
The global  portable oxygen concentrators market  is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Billion by the end of the year 2022 and surpass a projection of US$ 5.0 Billion by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Billion of the global oxygen concentrators market. Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards ...
Read more

Helicobacter Pylori Infections Treatment Market Research and Analysis 2023 to 2033

Image
The global helicobacter pylori infections treatment market is predicted to reach US$ 638.3 Million in 2023, with a compound annual growth rate (CAGR) of 7.04% anticipated from 2023 to 2033, reaching US$ 1,260 Million. The spread of such infections can be attributed to a number of factors, including a lack of adequate water supply, poor sanitation, a large population, and poor personal hygiene. One of the factors influencing the Helicobacter pylori diagnostics market's growth is increased awareness of H. pylori infections in the cohort. Antibiotic availability and affordability, as well as quicker processing times, will boost antibiotic use and the need for pre and post-surveillance tests. Furthermore, rising H. pylori infection rates, the need for early symptom diagnosis, and technological advances in diagnostic methods are expected to fuel overall growth over the forecast period. The key drivers of the industry are the increasing prevalence of communicable diseases and rising pub...
Read more

Pediatric Clinical Trials Market size is set to Grow at a Remarkable Pace by 2032

Image
During the forecast period 2022 to 2032, the global pediatric clinical trials market  is expected to grow at a value of 5.3%, according to Future Market Insights. In 2022, this market was predicted to have a global valuation of US$ 15.8 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing demand owing to the increase of pediatric chronic and genetic diseases all across the world. The growing need for novel vaccines and biopharmaceuticals to treat infectious diseases such as measles, polio, tuberculosis, rubella, influenza, mumps, whooping cough, malaria, chickenpox, and staphylococcus pharyngitis is expected to drive market growth. At the same time, diabetes is a big worry among today's children. The market is being driven by rising parental awareness of children clinical trials for severe infections and chronic diseases, as well as a large number of CROs doing pediatric research. In 2021, the onc...
Read more